Mercury Fund — 2025 Investments
5 investments dated 2025 · listed companies and verified rows first · show all
Houston, US
Collin McLelland(Executive Officer, Director)Jacob Corley(Director)
BoardCharles Yates(Director)
Board seatBlair Garrou· per SEC Form D · $7.4M raise · filed Mar 2025
Houston, US
Sameer Soleja(Executive Officer, Director)
BoardChristian Stewart(Director)Nate Quinn(Director)Doug Wendler(Director)
Board seatBlair Garrou· per SEC Form D · $11.9M raise · filed Jul 2025
Civitech builds technology infrastructure for political candidates, social causes, and local governments to increase voter registration and engagement.
Enterprise SoftwareGovTechSaaSSan Antonio, US
Jeremy Smith(CEO and Co-founder)Dan Graham(Director)Stephanie Fisher(Executive Officer)Erin Fahy(Chief Technology Officer of Issuer)Sarah Jackel(Executive Officer)
BoardTamer Mokhtar(Director)
Co-investorsAIN VenturesBuilders + BackersHigher Ground LabsScout VenturesScout VenturesGaingels
Liquibase provides a platform for governing and automating database change management across pipelines, platforms, and teams, integrating with tools like ServiceNow, GitHub, Harness, and Terraform.
Data & InfrastructureDeveloper ToolsEnterprise Software
Robert(Co-founder)Pete(Co-founder)Nathan(Founder (Liquibase open-source project))Patti(Chief Executive Officer)Ryan(Chief Customer Officer / Customer Success)Steve Surace(Vice President of Engineering)
Co-investorsS3 VenturesRiver Cities Capital
Nectar Allergy & Asthma is an allergy care platform offering testing, diagnosis, and treatment for food and environmental allergies, asthma, and eczema, including at-home testing kits and custom sublingual immunotherapy drops.
Digital HealthDirect to ConsumerHealthtechNew York City, US
Hersh Patel(Founder)
Co-investorsGold House VenturesHarmony PartnersObvious VenturesTrust FundGV (Google Ventures)Menlo Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.